Biotech Values

[DewDiligence]

What’s the least likely drug/biotech acquisition? PG acquiring Teva must be near the top of the list. Nevertheless, there’s a fund manager who thinks such a transaction is plausible:

http://www.kypost.com/dpps/money/business_news/pg-pg-happy-with-teva-partnership-investor-says-acquisition-is-logical-next-step_8377406

An Israeli pharmaceutical company that launched a joint venture with Procter & Gamble Co. in 2011 would make a logical acquisition target for Cincinnati-based P&G, according to John Park, an investor in Teva Pharmaceutical Industries Ltd. and managing director of Jackson Park Capital in Utah.

I wonder if Mr. Park realizes PG had a pretty substantial drug business before it was divested in 2009 (#msg-40785547).

Thanks to ‘midastouch017’ for this find.